EMAIL THIS PAGE TO A FRIEND

Oncotarget

Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition.


PMID 25483104

Abstract

We're sorry this abstract is currently not available.